CIPLANSECipla Limited· PharmaceuticalsMediumPositive
Announced Wed, 13 May · 12:45 IST

Cipla Limited has informed the Exchange that Record date for the purpose of Dividend is 05-Jun-2026.

Corporate Actions View source PDF

CIPLA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+10.9%1-day move
₹1293.70
prior close
₹1328.40
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.9-0.5-0.2+1.4+10.9+10.4+10.2+8.9+8.2+7.7+8.4+6.8+10.3
Up moveDown movePending
AI summary

Cipla Limited reported consolidated net profit of ₹542.51 Crores for FY 2025-26, a significant decline from ₹3,861.74 Crores in FY25, largely due to an exceptional charge of ₹275.91 Crores from new labour codes implementation and ₹42.02 Crores impairment in associate investments. Standalone net profit fell to ₹3,515.18 Crores vs ₹5,157.65 Crores in the prior year. The Board recommended a final dividend of INR 13 per equity share (face value ₹2 each), subject to shareholder approval at the AGM. Revenue from operations (standalone) was relatively flat at ₹18,979.95 Crores vs ₹19,044.85 Crores. EPS for standalone was ₹43.52 compared to ₹63.87 in FY25. The company completed acquisition of Inzpera Healthsciences Limited in December 2025.

Likely market impact

The significant profit decline and lower EPS may put pressure on Cipla's stock price in the near term. However, the maintained dividend of ₹13 per share signals management confidence. Record date for dividend is June 5, 2026.